Lantern Pharma, Inc. LTRN 深 沪
等待开盘 05-20 09:30:00 美东时间
3.09
+0.090
+3.00%
华盛通- 最 高3.13
- 今 开3.07
- 成交量 11.81万股
- 最 低 2.90
- 昨 收 3.00
- 总市值 3942.49万
- 52周最高 5.7441
- 市盈率 静 --
- 换手率 0.93%
- 52周最低 1.11
- 委 比 98.13%
- 总股本 1275.89万
- 历史最高 24.84
- 量 比 0.18
- 振 幅 7.67%
- 历史最低 1.11
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 635.6% to $2.0...
05-18 20:05
美股夜盘 | DirectBooking Technology Co., Ltd. Class A涨38.62%，WEX Inc.涨19.54%
P3 Health Partners Inc. Class A涨-17.63%；Artelo Biosciences Inc涨-14.67%；Lantern Pharma, Inc.涨-12.42%
05-18 08:05
Lantern Pharma Q1 EPS $(0.30) Beats $(0.36) Estimate
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 28.57 percent increase over losses of $(0.42) per share from
05-16 04:01
Earnings Scheduled For May 15, 2026
Companies Reporting Before The Bell • Traws Pharma (NASDAQ:TRAW) is expected to...
05-15 19:11
Lantern Pharma Announces Up To $9.25M Direct Offering With Existing Shareholders And Unnamed Institutional Investor; Transaction Expected To Close May 14
Lantern Pharma announced that it has entered into a definitive agreement for the purchase and sale of an aggregate of 2,135,923 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of
05-13 20:09
Lantern Pharma Expands Its predictBBB.ai Web Service Into A Large Quantitative Model
For the first time, pharmaceutical scientists and medicinal chemists can access a unified, benchmark-validated LQM — not as a batch software installation, not as a siloed cheminformatics tool — but as an on-demand
04-29 20:56
Lantern Pharma Schedules FDA Type C Meeting To Refine HARMONIC Trial For LP-300 In EGFR L858R NSCLC, Highlighting Progression-Free Survival Signals
Lantern Pharma Schedules Type C Meeting with the FDA to Advance HARMONIC™ Protocol Amendments Targeting This High-Need Population, Reflecting LP-300's Novel Mechanism of Action and the Rapidly Evolving Post-TKI
04-20 20:14
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% t...
03-31 20:05
Lantern Pharma Q4 EPS $(0.36) Beats $(0.46) Estimate
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.46) by 21.74 percent. This is a 33.33 percent increase over losses of $(0.54) per share from
03-31 04:22
Why Is Lantern Pharma Stock Soaring Monday?
Lantern Pharma shares rebound in premarket trading as the company debunks a false report regarding CEO Panna Sharma's departure.
03-30 21:33
